These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model. Wong VS, Wight DG, Palmer CR, Alexander GJ. J Clin Pathol; 1996 Jun; 49(6):465-9. PubMed ID: 8763259 [Abstract] [Full Text] [Related]
5. Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course. Reichard O, Glaumann H, Norkrans G, Wejstål R, Fryden A, Schvarcz R, Weiland O. Liver; 1994 Aug; 14(4):169-74. PubMed ID: 7526108 [Abstract] [Full Text] [Related]
6. Histologic changes in liver biopsy specimens produced by recombinant interferon alpha-2b therapy for chronic non-A,non-B viral hepatitis. A randomized controlled trial. David E, Pucci A, Palladin D, Saracco G, Garello E, Pintus C, Rocca G, Chiandussi L, Solinas A, Mollo F. Am J Clin Pathol; 1992 Oct; 98(4):397-401. PubMed ID: 1415021 [Abstract] [Full Text] [Related]
8. A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C. Banner BF, Barton AL, Cable EE, Smith L, Bonkovsky HL. Mod Pathol; 1995 Apr; 8(3):232-8. PubMed ID: 7542385 [Abstract] [Full Text] [Related]
9. The histopathological features of asymptomatic hepatitis C virus-antibody positive blood donors. McMahon RF, Yates AJ, McLindon J, Babbs C, Love EM, Warnes TW. Histopathology; 1994 Jun; 24(6):517-24. PubMed ID: 7520412 [Abstract] [Full Text] [Related]
10. Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation. Fernández I, Meneu JC, Colina F, García I, Muñoz R, Castellano G, Fuertes A, Abradelo M, Lumbreras C, Moreno E, Solís-Herruzo JA. Liver Transpl; 2006 Dec; 12(12):1805-12. PubMed ID: 17133585 [Abstract] [Full Text] [Related]
11. Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy. El-Zayadi AR, Attia M, Badran HM, El-Tawil A, Zalata K, Barakat E, Selim O, El-Nakeeb A, Saied A. Liver Int; 2005 Aug; 25(4):746-51. PubMed ID: 15998425 [Abstract] [Full Text] [Related]
14. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, Kamada T. Hepatology; 1994 Apr; 19(4):871-5. PubMed ID: 8138259 [Abstract] [Full Text] [Related]
15. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis. Mochida S, Ohnishi K, Matsuo S, Kakihara K, Fujiwara K. Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):371A-377A. PubMed ID: 8986241 [Abstract] [Full Text] [Related]
16. [Histological evaluation of the liver and response to interferon in chronic hepatitis C]. Yoshida H, Iwabuchi S, Murayama M, Uchikoshi T. Nihon Rinsho; 1994 Jul; 52(7):1763-8. PubMed ID: 8078200 [Abstract] [Full Text] [Related]
18. Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults. Assy N, Minuk GY. Am J Gastroenterol; 2000 Jun; 95(6):1545-50. PubMed ID: 10894594 [Abstract] [Full Text] [Related]
19. Histological features predictive of liver fibrosis in chronic hepatitis C infection. Paradis V, Mathurin P, Laurent A, Charlotte F, Vidaud M, Poynard T, Hoang C, Opolon P, Bedossa P. J Clin Pathol; 1996 Dec; 49(12):998-1004. PubMed ID: 9038738 [Abstract] [Full Text] [Related]
20. Relationship between the intrahepatic expression of interferon-alpha receptor mRNA and the histological progress of hepatitis C virus-associated chronic liver diseases. Ishimura N, Fukuda R, Fukumoto S. J Gastroenterol Hepatol; 1996 Aug; 11(8):712-7. PubMed ID: 8872766 [Abstract] [Full Text] [Related] Page: [Next] [New Search]